Puma Biotechnology Inc CEO Alan Auerbach Sells 41,396 Shares
Puma Biotechnology, Inc. 2023 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. | LinkedIn
Puma Biotech's Stock Soars to New High, but Technical Analysis Signals Caution
Alan H. Auerbach - Los Angeles Business Journal
Puma Biotechnology Presents P-II (SUMMIT) Basket Trial Results of Neratinib for EGFR Exon 18-Mutant NSCLC at EORTC/NCI/AACR 2022
Articles about Puma Biotechnology
Shortened FDA Advisory Panel Is Bad Omen for Puma Bio's Controversial Breast Cancer Drug - TheStreet
Puma Biotechnology: Profitable, Troubled, But Worth A Good Look (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Reports Results of PB272 (neratinib) in P-III NALA Trial for Patients with 2L+ HER2+ Metastatic Breast Cancer #ASCO2019
Buy Puma Biotechnology Stock - PBYI Stock Price Today & News - Public.com
Puma Biotechnology Inc CEO Alan Auerbach Sells 41,396 Shares
Puma Biotechnology NPS & Customer Reviews | Comparably
Puma Biotechnology (PBYI) Presents At Barclays Global Healthcare Virtual Conference (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Price-Forecasting Models for Puma Biotechnology PBYI Stock : Ta, Ton Viet: Amazon.sg: Books
Puma Biotechnology
Daiichi Sankyo US on LinkedIn: Daiichi Sankyo and Puma Biotechnology have announced a…
Puma Biotechnology begins Phase II trial of lung cancer drug
Puma Biotechnology Surging
Puma Biotechnology and Pierre Fabre Enter into Exclusive License Agreement to Develop and Commercialize NERLYNX® (neratinib) in Europe | Business Wire
Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor | Business Wire
Puma Biotechnology Inc (PBYI) Reports Positive Net Income for Q4 and Full Year 2023
Puma Biotechnology Inc Stock | 3d-mon.com
PumaBiotech (@pumabiotech) / X
Puma Biotechnology, Inc. | LinkedIn
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Puma Biotechnology
$16-$32/hr Puma Biotechnology Jobs (NOW HIRING) Apr 2024
